실시간
FierceBiotechKurma closes €215M Europe-focused fund to spread across 20 biotechsFierceBiotechPfizer cans work on next-gen conjugate in cancer patientsThermo FisherThermo Fisher (TMO) Q1 2026 Earnings Transcript - The Motley FoolLonza NewsBanks kick off talks on Lone Star’s $1.75 billion Lonza unit debt - Bloomberg News - TradingViewPromega BlogThe Body Already KnowsLonza NewsBanks Kick Off Talks on Lone Star’s €1.5 Billion Lonza Unit Debt - Bloomberg.comThermo FisherThermo Fisher Scientific Q1 2026 Earnings Call: Complete Transcript - BenzingaThermo FisherThermo Fisher stock drops despite Q1 beat (update) (TMO:NYSE) - Seeking AlphaBioWorldAvacta Life Sciences patents FAP-activated camptothecin conjugatesBioWorldMabwell discloses new ADAM9-targeting ADCsBioWorldFosun Pharma discovers new PKMYT1 inhibitorsBioWorldChengdu Mfs Pharma synthesizes new compounds for pain
FierceBiotech 2025년 12월 17일

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B

원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.